105 related articles for article (PubMed ID: 9271492)
1. A cysteine-3 to serine mutation of the G-protein Gi1 alpha abrogates functional activation by the alpha 2A-adrenoceptor but not interactions with the beta gamma complex.
Wise A; Grassie MA; Parenti M; Lee M; Rees S; Milligan G
Biochemistry; 1997 Sep; 36(35):10620-9. PubMed ID: 9271492
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor.
Bahia DS; Wise A; Fanelli F; Lee M; Rees S; Milligan G
Biochemistry; 1998 Aug; 37(33):11555-62. PubMed ID: 9708991
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins.
Wise A; Sheehan M; Rees S; Lee M; Milligan G
Biochemistry; 1999 Feb; 38(8):2272-8. PubMed ID: 10029519
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the alpha2A-adrenoceptor with multiple Gi-family G-proteins: studies with pertussis toxin-resistant G-protein mutants.
Wise A; Watson-Koken MA; Rees S; Lee M; Milligan G
Biochem J; 1997 Feb; 321 ( Pt 3)(Pt 3):721-8. PubMed ID: 9032459
[TBL] [Abstract][Full Text] [Related]
5. Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits.
Federman AD; Conklin BR; Schrader KA; Reed RR; Bourne HR
Nature; 1992 Mar; 356(6365):159-61. PubMed ID: 1312225
[TBL] [Abstract][Full Text] [Related]
6. Rescue of functional interactions between the alpha2A-adrenoreceptor and acylation-resistant forms of Gi1alpha by expressing the proteins from chimeric open reading frames.
Wise A; Milligan G
J Biol Chem; 1997 Sep; 272(39):24673-8. PubMed ID: 9305937
[TBL] [Abstract][Full Text] [Related]
7. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
[TBL] [Abstract][Full Text] [Related]
8. Mutation of cysteine 214 in Gi1 alpha subunit abolishes its endogenous GTPase activity.
Wang Y; Tawa G; Smith D; Krishnamurthy G; Young KH
Biochem J; 2004 May; 379(Pt 3):673-9. PubMed ID: 14725508
[TBL] [Abstract][Full Text] [Related]
9. Molecular interaction of the human alpha 2-C10-adrenergic receptor, when expressed in Rat-1 fibroblasts, with multiple pertussis toxin-sensitive guanine nucleotide-binding proteins: studies with site-directed antisera.
McClue SJ; Milligan G
Mol Pharmacol; 1991 Nov; 40(5):627-32. PubMed ID: 1658601
[TBL] [Abstract][Full Text] [Related]
10. Alterations in guanine nucleotide regulatory protein expression and activity in human hepatocellular carcinoma.
Schmidt CM; McKillop IH; Cahill PA; Sitzmann JV
Hepatology; 1997 Nov; 26(5):1189-94. PubMed ID: 9362361
[TBL] [Abstract][Full Text] [Related]
11. Partial rescue of functional interactions of a nonpalmitoylated mutant of the G-protein G alpha s by fusion to the beta-adrenergic receptor.
Ugur O; Onaran HO; Jones TL
Biochemistry; 2003 Mar; 42(9):2607-15. PubMed ID: 12614155
[TBL] [Abstract][Full Text] [Related]
12. Reciprocal modulation of alpha(2A)-adrenoceptor and G(alpha o) protein states as determined by carboxy-terminal mutagenesis of a G(alpha o) protein.
Wurch T; Okuda J; Pauwels PJ
Mol Pharmacol; 2001 Oct; 60(4):666-73. PubMed ID: 11562427
[TBL] [Abstract][Full Text] [Related]
13. Targeting of a G alpha subunit (Gi1 alpha) and c-Src tyrosine kinase to caveolae membranes: clarifying the role of N-myristoylation.
Song KS; Sargiacomo M; Galbiati F; Parenti M; Lisanti MP
Cell Mol Biol (Noisy-le-grand); 1997 May; 43(3):293-303. PubMed ID: 9193783
[TBL] [Abstract][Full Text] [Related]
14. Loss of activation of Gs but not Gi following expression of an alpha2A-adrenoceptor-Gi1alpha fusion protein.
Sautel M; Milligan G
FEBS Lett; 1998 Sep; 436(1):46-50. PubMed ID: 9771891
[TBL] [Abstract][Full Text] [Related]
15. The role of Gi proteins in reduced vasorelaxation response to beta-adrenoceptor agonists in rat aorta during maturation.
Baloğlu E; Kiziltepe O; Gürdal H
Eur J Pharmacol; 2007 Jun; 564(1-3):167-73. PubMed ID: 17395174
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors.
Tsu RC; Allen RA; Wong YH
Mol Pharmacol; 1995 Apr; 47(4):835-41. PubMed ID: 7723745
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of adenylyl cyclase by octopamine via a human cloned alpha 2A-adrenoceptor.
Airriess CN; Rudling JE; Midgley JM; Evans PD
Br J Pharmacol; 1997 Sep; 122(2):191-8. PubMed ID: 9313925
[TBL] [Abstract][Full Text] [Related]
18. The effect of site-directed mutagenesis of two transmembrane serine residues on agonist-specific coupling of a cloned human alpha2A-adrenoceptor to adenylyl cyclase.
Rudling JE; Kennedy K; Evans PD
Br J Pharmacol; 1999 Jun; 127(4):877-86. PubMed ID: 10433494
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Gi-protein-mediated mitogenesis following chronic ethanol exposure in a rat model of experimental hepatocellular carcinoma.
McKillop IH; Vyas N; Schmidt CM; Cahill PA; Sitzmann JV
Hepatology; 1999 Feb; 29(2):412-20. PubMed ID: 9918917
[TBL] [Abstract][Full Text] [Related]
20. Structural requirements for G(o) activation by receptor-derived peptides: activation and modulation domains of the alpha 2-adrenergic receptor i3c region.
Wade SM; Scribner MK; Dalman HM; Taylor JM; Neubig RR
Mol Pharmacol; 1996 Aug; 50(2):351-8. PubMed ID: 8700143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]